Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Disease
A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid...
Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Disease
Developing Accessible Monoclonal Antibodies to Treat COVID-19
Optimizing Health System Resources for Patients Needing Acute Care
Using Biosimulation to Develop Pediatric Therapeutics
Building Digitally-Enabled Healthcare Tools to Serve a Global Audience
Advanced Skin Cancer Diagnostic Tests Overlay Biology on Top of Pathology to Determine...